Our two main divisions are LOMINA AG and LOMINA Superbio a.s., during which time LOMINA Superbio focuses on development and manufacture of in vitro diagnostic medical devices (IVD).
Lomina Group has been established in 2007 in Switzerland as an A.G. LOMINA AG is also registered as Organizational Unit in the Czech Republic. Subsidiary LOMINA SUPERBIO a.s. was established in August 2018 in the Czech Republic.
Our companies are completely independent. 100% of shareholders are European individuals and LOMINA is not anyhow depending on any out of EU entity. We don’t use any offshores and fully tax in EFTA (EU+Switzerland).
We are constantly delivering required business results, meeting deadlines and productivity and performance standards.
We offer more than 500 types of IVD assay, including assays for certain very rare diseases. We also offer OEM/OBL production.
We manufacture laboratory in vitro diagnostic devices (IVD), which react to a number of diseases, including infections, tumours, cardiac disease and others.
The Lomina Mobile Laboratory (LOMINA LAB) is a diagnostic kit in the form of a diagnostic IVD case, intended for easy and fast collection and assessment of diagnostic assays, including biochemical values.
The group is ISO 13485:2016 certified in a good stand by British Certification Authority NQA-UKAS. Last re-certification took has been done in June 2021.
The company follows also ISO:9001 and we consider official certification to be done during next annual re-audit on 2022.
All LOMINA products are registered at Czech RZPRO and European EUDAMED database.
All LOMINA products are registered In accordance with Directive 98/79/EC of the European Parliament and of the Council and according to: